John Quackenbush is Professor of Computational Biology and Bioinformatics and Chair of the
Department of Biostatistics at the Harvard TH Chan School of Public Health and Professor in the
Channing Division of Network Medicine at Brigham and Women’s Hospital and in the Department of
Data Science at the Dana-Farber Cancer Institute. John’s PhD was in Theoretical Physics, but in 1992 he
received a fellowship to work on the Human Genome Project. This led him through the Salk Institute,
Stanford University, and The Institute for Genomic Research (TIGR), before moving to Harvard in 2005.
John’s research uses massive data to probe how many small effects combine to influence our health and
risk of disease. He has published more than 320 scientific papers that have collectively been cited over
85,000 times and among his honors is recognition in 2013 as a White House Open Science Champion of
Change. In 2012, he founded Genospace, a precision medicine software company providing data
platforms to hospitals, diagnostic testing labs, and other groups. In 2017, Genospace was purchased by
the Hospital Corporation of America. He serves on numerous advisory boards, including those of Merck
KGaA, Caris Life Sciences, and RenalytixAI.
|